The ticker symbol ANTX represents equity shares in AN2 Therapeutics, Inc., a publicly traded clinical-stage biopharmaceutical company listed on the Nasdaq Stock Market. Purchasing shares grants investors fractional ownership in the enterprise, exposing them to the financial risks and potential rewards associated with its drug discovery pipeline, clinical trial progress, and therapeutic treatments targeting serious infectious diseases.